Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Int.biotech. (IBT) Share News

SV Health notifies International Biotechnology of termination in 2024

13th Feb 2023 11:54

(Alliance News) - International Biotechnology Trust PLC on Monday said it received a notice of termination from investment manager SV Health Managers LLP, which said it wants to focus on its core healthcare venture business. Read More

SMALL-CAP WINNERS & LOSERS: Non-Standard drops on insolvency warning

13th Feb 2023 10:02

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday. Read More

TRADING UPDATES: Altona extends repayment; Kefi advances Saudi Arabia

3rd Feb 2023 16:30

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

UK dividends calendar - next 7 days

20th Jan 2023 15:45

Read More

UK dividends calendar - next 7 days

22nd Dec 2022 15:44

Read More

TRADING UPDATES: Poolbeg acquires license; Afentra expects PSA delay

14th Dec 2022 21:54

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

29th Nov 2022 15:56

Read More

EARNINGS SUMMARY: Vulcan Industries and Wildcat Petroleum narrow loss

1st Nov 2022 14:48

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

UK dividends calendar - next 7 days

19th Aug 2022 16:03

Read More

UK dividends calendar - next 7 days

21st Jul 2022 16:12

Read More

UK dividends calendar - next 7 days

7th Jul 2022 16:02

Read More

IN BRIEF: International Biotechnology NAV gets Pfizer-Biohaven boost

11th May 2022 17:46

International Biotechnology Trust PLC - London-based investment trust managed by SV Health Managers LLP - Says Pfizer Inc's acquisition of its investee Biohaven Pharmaceutical Holding Co Ltd has boosted net asset value by 3.6%. Pfizer on Tuesday announced the acquisition of Biohaven for USD148.50 per share, at a 74% premium to the price of Biohaven before the announcement. IBT on Tuesday owned 182,000 shares in Biohaven, which constituted around 5.2% of its NAV. Read More

Pfizer's USD12 billion deal for Biohaven could jump-start sector M&A

10th May 2022 18:12

(Alliance News) - Pfizer Inc's move to acquire migraine therapy maker Biohaven Pharmaceutical Holding Co Ltd could spark a wave of M&A sector activity as drugmakers sit on large piles of cash. Read More

IN BRIEF: International Biotechnology notes Pfizer buys investee

10th May 2022 15:27

International Biotechnology Trust PLC - London-based investment trust managed by SV Health Managers LLP - Notes it has stake in Biohaven Pharmaceutical Holding Co Ltd, a pharmaceutical firm which Pfizer Inc has agreed to acquire for USD11.6 billion. Biohaven is International Biotechnology's seventh-largest holding, representing 4.1% of its net asset value as of March 31. International Biotechnology co-manager Ailsa Craig says deal represents sign "Covid cash" is being put to use on M&A in pharmaceutical sector. The trust notes Biohaven is not a constituent of its benchmark Nasdaq Biotech Index. Biohaven is listed on the New York Stock Exchange. Read More

IN BRIEF: International Biotechnology Trust corrects interim return

6th May 2022 12:13

International Biotechnology Trust PLC - London-based investment trust managed by SV Health Managers LLP - Company corrects that, for the six months that ended February 28, its net asset value per share total return was negative 15%, rather than the 13% reported on Wednesday, while the company's benchmark, the Nasdaq Biotechnology Index, returned negative 23%. The correction to the return relates to dividends paid. The trust swung to a pretax loss of GBP48.5 million in the six months from a profit of GBP19.1 million a year previous. International Biotechnology Trust makes a GBP46.5 million loss on investments, versus a gain of GBP20.4 million a year before. NAV per share stands at 648.82 pence at February 28, down from 775.73p a year previous. Says the biotechnology sector has experienced a "significant" period of weakness, but the company's outlook remains positive. Read More

EARNINGS UPDATES: Dianomi swings to loss; Vaalco quarterly sales surge

4th May 2022 16:53

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

IN BRIEF: International Biotechnology aims to invest in SV Health fund

31st Dec 2021 10:32

IN BRIEF: International Biotechnology aims to invest in SV Health fund Read More

UK dividends calendar - next 7 days

23rd Dec 2021 15:54

UK dividends calendar - next 7 days Read More

UK shareholder meetings calendar - next 7 days

1st Dec 2021 16:07

UK shareholder meetings calendar - next 7 days Read More

EXECUTIVE CHANGES: JD Sports adds former Mars, McDonalds exec to board

30th Nov 2021 16:13

EXECUTIVE CHANGES: JD Sports adds former Mars, McDonalds exec to board Read More

FTSE 100 Latest
Value8,992.12
Change19.48